$3.32
5.06% day before yesterday
Nasdaq, Oct 03, 10:18 pm CET
ISIN
US0144421072
Symbol
ALEC

Alector, Inc. Stock price

$3.32
+0.53 19.00% 1M
+2.23 204.59% 6M
+1.43 75.66% YTD
-0.90 21.33% 1Y
-6.00 64.38% 3Y
-7.50 69.32% 5Y
-13.31 80.04% 10Y
-13.31 80.04% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
+0.16 5.06%
ISIN
US0144421072
Symbol
ALEC
Industry

Key metrics

Basic
Market capitalization
$336.0m
Enterprise Value
$38.3m
Net debt
positive
Cash
$307.3m
Shares outstanding
101.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.1 | 20.4
EV/Sales
0.5 | 2.3
EV/FCF
negative
P/B
4.7
Financial Health
Equity Ratio
27.1%
Return on Equity
-93.9%
ROCE
-49.4%
ROIC
1,939.1%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$81.1m | $16.5m
EBITDA
$-123.5m | $-173.3m
EBIT
$-134.5m | $-174.2m
Net Income
$-115.3m | $-158.3m
Free Cash Flow
$-216.0m
Growth (TTM | estimate)
Revenue
46.8% | -83.6%
EBITDA
32.0% | -27.3%
EBIT
28.2% | -20.2%
Net Income
28.3% | -33.0%
Free Cash Flow
0.8%
Margin (TTM | estimate)
Gross
-
EBITDA
-152.2% | -1,049.9%
EBIT
-165.8%
Net
-142.1% | -958.8%
Free Cash Flow
-266.3%
More
EPS
$-1.2
FCF per Share
$-2.1
Short interest
7.3%
Employees
238
Rev per Employee
$420.0k
Show more

Is Alector, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Alector, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Alector, Inc. forecast:

11x Buy
73%
2x Hold
13%
2x Sell
13%

Analyst Opinions

15 Analysts have issued a Alector, Inc. forecast:

Buy
73%
Hold
13%
Sell
13%

Financial data from Alector, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
81 81
47% 47%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 58 58
1% 1%
71%
- Research and Development Expense 156 156
16% 16%
192%
-123 -123
32% 32%
-152%
- Depreciation and Amortization 11 11
92% 92%
14%
EBIT (Operating Income) EBIT -135 -135
28% 28%
-166%
Net Profit -115 -115
28% 28%
-142%

In millions USD.

Don't miss a Thing! We will send you all news about Alector, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alector, Inc. Stock News

Neutral
Seeking Alpha
12 days ago
Alector, Inc. - Special Call Company Participants Katie Hogan - Senior Director of Corporate Communication & Investor Relations Sara Kenkare-Mitra - President and Head of Research & Development Arnon Rosenthal - Co-Founder, CEO & Director Giacomo Salvadore - Chief Medical Officer Conference Call Participants Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division Myles Minter - William B...
Neutral
GlobeNewsWire
19 days ago
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced management will host a virtual event to discuss the company's progranulin (PGRN) franchise and Alector Brain Carrier (ABC)–enabled programs.
Neutral
Seeking Alpha
26 days ago
Alector, Inc. (NASDAQ:ALEC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT Company Participants Arnon Rosenthal - Co-Founder, CEO & Director Conference Call Participants Sean Laaman - Morgan Stanley, Research Division Presentation Sean Laaman Head of Healthcare Research & Equity Analyst Good morning, everyone, and welcome to Morgan Stanley Global Healthc...
More Alector, Inc. News

Company Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Head office United States
CEO Arnon Rosenthal
Employees 238
Founded 2013
Website alector.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today